Familial hypokalemia-hypomagnesemia: genes and variants
Explore variant evidence for Familial hypokalemia-hypomagnesemia across 2 analyzed proteins (SLC12A3, IDUA). Linked ClinVar records include 116 pathogenic or likely pathogenic variants, 172 variants of uncertain significance and 55 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial hypokalemia-hypomagnesemia
SLC12A3: Solute carrier family 12 member 3
It reabsorbs sodium and chloride in the distal convoluted tubule and is a major determinant of renal salt and magnesium handling. Biallelic loss-of-function variants cause Gitelman syndrome with hypokalemic metabolic alkalosis, hypomagnesemia, and low urinary calcium.
115 ClinVar pathogenic / likely pathogenic and 224 uncertain variants in SLC12A3 have source records linked to Familial hypokalemia-hypomagnesemia. Association strength is not clinical gene validity.
IDUA: Alpha-L-iduronidase
It removes terminal alpha-L-iduronic acid residues during lysosomal degradation of dermatan and heparan sulfate. Biallelic loss-of-function variants cause mucopolysaccharidosis type I, spanning severe Hurler syndrome to attenuated Scheie-spectrum disease.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IDUA have source records linked to Familial hypokalemia-hypomagnesemia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): SLC12A1 and CASR.
ClinVar pathogenic and likely pathogenic variants linked to Familial hypokalemia-hypomagnesemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SLC12A3 A523T | 523 | Extracellular | Pathogenic / likely pathogenic (★★★★) |
| SLC12A3 R145C | 145 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G394D | 394 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 C421Y | 421 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 C421R | 421 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 S615W | 615 | Scissor helix | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R145H | 145 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G316V | 316 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 P349L | 349 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 C421G | 421 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G439S | 439 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G463R | 463 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G463E | 463 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 A588E | 588 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 A588V | 588 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 S615L | 615 | Scissor helix | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R852C | 852 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R852H | 852 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R852L | 852 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G316A | 316 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 P349S | 349 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 Y540C | 540 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 M581K | 581 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R642H | 642 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R655C | 655 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R862P | 862 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R83Q | 83 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R83W | 83 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G201V | 201 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R209P | 209 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 L215P | 215 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 L272P | 272 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 T304M | 304 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 T304P | 304 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 A356V | 356 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 N359K | 359 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 S475C | 475 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R642G | 642 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R642C | 642 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 P643L | 643 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R655H | 655 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 L849H | 849 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 D62G | 62 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R209W | 209 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G374V | 374 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 T392I | 392 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 N442K | 442 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC12A3 A464T | 464 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 D486N | 486 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 Q617R | 617 | Scissor helix | Pathogenic / likely pathogenic (★★) |
| SLC12A3 L700P | 700 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 S967F | 967 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 T60M | 60 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 R158Q | 158 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 T163M | 163 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 W172R | 172 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 G186D | 186 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 L215F | 215 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC12A3 A226T | 226 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC12A3 T375N | 375 | Transmembrane | Pathogenic / likely pathogenic (★★) |
Showing 60 of 116.
Uncertain variants prioritized for review in Familial hypokalemia-hypomagnesemia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SLC12A3 R958W | 958 | Cytoplasmic | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; R958G at the same position is pathogenic; seen in 6.2e-06 of gnomAD DNA copies; REVEL 0.843 |
| SLC12A3 G141A | 141 | Transmembrane | Conflicting reports (★) | +6: in a 3D region that tolerates change poorly (1A); G141R at the same position is pathogenic; REVEL 0.881 |
| SLC12A3 S178L | 178 | Transmembrane | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; S178P at the same position is pathogenic; REVEL 0.778 |
| SLC12A3 D62N | 62 | Cytoplasmic | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; D62G at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.700 |
Which prediction tools work for Familial hypokalemia-hypomagnesemia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 95 out of 100
- ESM1b (LLR): 93 out of 100
- CADD: 93 out of 100
- CATVariant: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 90 out of 100
- MetaLR: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 85 out of 100
- SpliceAI: 56 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 41 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Renal tubulopathies also has ClinVar records linked to SLC12A3 variants; they fall in the same places as the Familial hypokalemia-hypomagnesemia variants (14 pathogenic / likely pathogenic).
- Mucopolysaccharidosis also has ClinVar records linked to IDUA variants; they fall mostly in different places as the Familial hypokalemia-hypomagnesemia variants (80 pathogenic / likely pathogenic).
- Hurler syndrome also has ClinVar records linked to IDUA variants; they fall mostly in different places as the Familial hypokalemia-hypomagnesemia variants (16 pathogenic / likely pathogenic).
- Hurler-Scheie syndrome also has ClinVar records linked to IDUA variants; they fall mostly in different places as the Familial hypokalemia-hypomagnesemia variants (6 pathogenic / likely pathogenic).
- Mucopolysaccharidosis, MPS-I-H/S also has ClinVar records linked to IDUA variants; they fall mostly in different places as the Familial hypokalemia-hypomagnesemia variants (3 pathogenic / likely pathogenic).
Diseases related to Familial hypokalemia-hypomagnesemia
- Mucopolysaccharidosis, also linked to IDUA
- Nephrotic syndrome, also linked to SLC12A3
- Bartter syndrome, also linked to SLC12A3
- Hurler syndrome, also linked to IDUA
- Renal tubulopathies, also linked to SLC12A3
- Hurler-Scheie syndrome, also linked to IDUA
- Myocardial infarction, also linked to SLC12A3
- Mucopolysaccharidosis, MPS-I-H/S, also linked to IDUA
Frequently asked questions
Which genes have records linked to Familial hypokalemia-hypomagnesemia?
This view contains 2 analyzed proteins: SLC12A3, IDUA. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 116 pathogenic or likely pathogenic variants, 172 variants of uncertain significance and 55 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 4 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 351 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center